Sonoporation: Applications for cancer therapy

Advances in Experimental Medicine and Biology

Volumn 880, Issue , 2016, Pages 263-291

  Qin, Jiale ^a   Wang, Tzu Yin ^a   Willmann, Jürgen K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Drug delivery; Sonoporation

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE;

ARTICLE; CANCER IMMUNIZATION; CANCER PREVENTION; CANCER RESISTANCE; CANCER THERAPY; CELL MEMBRANE TRANSPORT; CELL TRANSPORT; CLINICAL PROTOCOL; DRUG DELIVERY SYSTEM; DRUG SAFETY; HUMAN; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SONOPORATION; TRANSPORT KINETICS; TREATMENT PLANNING; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ULTRASOUND; VASCULAR ENDOTHELIUM; MICROBUBBLE; NEOPLASMS; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; HUMANS; MICROBUBBLES; NEOPLASMS; TUMOR MICROENVIRONMENT; ULTRASONICS;

EID: 84962657392     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-22536-4_15     Document Type: Article

References (123)

1. Apfel RE, Holland CK (1991) Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 17:179–185.
2. Bachawal SV, Jensen KC, Lutz AM, Gambhir SS, Tranquart F, Tian L, Willmann JK (2013) Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res 73:1689–1698.
3. Bae YH (2009) Drug targeting and tumor heterogeneity. J Control Release 133:2–3.
4. Bekeredjian R, Kroll RD, Fein E, Tinkov S, Coester C, Winter G, Katus HA, Kulaksiz H (2007) Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. Ultrasound Med Biol 33:1592–1598.
5. Bohmer MR, Chlon CH, Raju BI, Chin CT, Shevchenko T, Klibanov AL (2010) Focused ultrasound and microbubbles for enhanced extravasation. J Control Release 148:18–24.
6. Borden MA, Caskey CF, Little E, Gillies RJ, Ferrara KW (2007) DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 23:9401–9408.
7. Boucher Y, Baxter LT, Jain RK (1990) Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50:4478–4484.
8. Brayman AA, Coppage ML, Vaidya S, Miller MW (1999) Transient poration and cell surface receptor removal from human lymphocytes in-vitro by 1.MHz ultrasound. Ultrasound Med Biol 25:999–1008.
9. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502.
10. Carlisle R, Choi J, Bazan-Peregrino M, Laga R, Subr V, Kostka L, Ulbrich K, Coussios CC, Seymour LW (2013) Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound. J Natl Cancer Inst 105:1701–1710.
11. Carson AR, McTiernan CF, Lavery L, Grata M, Leng X, Wang J, Chen X, Villanueva FS (2012) Ultrasoundtargeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res 72:6191–6199.
12. Caskey CF, Stieger SM, Qin S, Dayton PA, Ferrara KW (2007) Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall. J Acoust Soc Am 122:1191–1200.
13. Chen H, Kreider W, Brayman AA, Bailey MR, Matula TJ (2011) Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett 106:034301.
14. Chiang CL, Benencia F, Coukos G (2010) Whole tumor antigen vaccines. Semin Immunol 22:132–143.
15. Chuang YH, Wang YH, Chang TK, Lin CJ, Li PC (2014) Albumin acts like transforming growth factor beta1 in microbubble-based drug delivery. Ultrasound Med Biol 40:765–774.
16. Cochran MC, Eisenbrey J, Ouma RO, Soulen M, Wheatley MA (2011a) Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm 414:161–170.
17. Cochran MC, Eisenbrey JR, Soulen MC, Schultz SM, Ouma RO, White SB, Furth EE, Wheatley MA (2011b) Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model. Acad Radiol 18:1341–1348.
18. Davies Cde L, Lundstrom LM, Frengen J, Eikenes L, Bruland SO, Kaalhus O, Hjelstuen MH, Brekken C (2004) Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts. Cancer Res 64:547–553.
19. De Temmerman ML, Dewitte H, Vandenbroucke RE, Lucas B, Libert C, Demeester J, De Smedt SC, Lentacker I, Rejman J (2011) mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells. Biomaterials 32: 9128–9135.
20. Deng Z, Yan F, Jin Q, Li F, Wu J, Liu X, Zheng H (2014) Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound. J Control Release 174:109–116.
21. Deshpande N, Needles A, Willmann JK (2010) Molecular ultrasound imaging: current status and future directions. Clin Radiol 65:567–581.
22. Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH (2008) High-intensity focused ultrasound: current potential and oncologic applications. Am J Roentgenol 190:191–199.
23. Ducreux M, Rougier P, Fandi A, Clavero-Fabri MC, Villing AL, Fassone F, Fandi L, Zarba J, Armand JP (1998) Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 9:653–656.
24. Duvshani-Eshet M, Benny O, Morgenstern A, Machluf M (2007) Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth. Mol Cancer Ther 6:2371–2382.
25. Edelstein ML, Abedi MR, Wixon J (2007) Gene therapy clinical trials worldwide to 2007--an update. J Gene Med 9:833–842.
26. Eggen S, Afadzi M, Nilssen EA, Haugstad SB, Angelsen B, Davies Cde L (2013) Ultrasound improves the uptake and distribution of liposomal Doxorubicin in prostate cancer xenografts. Ultrasound Med Biol 39:1255–1266.
27. Eggen S, Fagerland SM, Morch Y, Hansen R, Sovik K, Berg S, Furu H, Bohn AD, Lilledahl MB, Angelsen A, Angelsen B, de Lange DC (2014) Ultrasoundenhanced drug delivery in prostate cancer xenografts by nanoparticles stabilizing microbubbles. J Control Release 187:39–49.
28. Eikenes L, Bruland OS, Brekken C, Davies Cde L (2004) Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res 64:4768–4773.
29. Elodie Debefve YW, Krueger T, van den Bergh H (2013) Photodynamic therapy for increased delivery of anticancer drugs. In: Handbook of photomedicine. CRC Press, Florida
30. Fan Z, Liu H, Mayer M, Deng CX (2012) Spatiotemporally controlled single cell sonoporation. Proc Natl Acad Sci U S A 109:16486–16491.
31. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2014) Cancer worldwide. In: Stewart BW, Wild CP (eds) World cancer report 2014, vol 3. International Agency for Research on Cancer (IARC), Lyon, pp 16–80.
32. Foygel K, Wang H, Machtaler S, Lutz AM, Chen R, Pysz M, Lowe AW, Tian L, Carrigan T, Brentnall TA, Willmann JK (2013) Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology 4:885–894.
33. Fujii H, Matkar P, Liao C, Rudenko D, Lee PJ, Kuliszewski MA, Prud’homme GJ, Leong-Poi H (2013) Optimization of ultrasound-mediated anti-angiogenic cancer gene therapy. Mol Ther Nucleic Acids 2, e94.
34. Fukumura D, Jain RK (2007) Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 101:937–949.
35. Ghoshal G, Swat S, Oelze ML (2012) Synergistic effects of ultrasound-activated microbubbles and doxorubicin on short-term survival of mouse mammary tumor cells. Ultrason Imaging 34:15–22.
36. Goertz DE, Todorova M, Mortazavi O, Agache V, Chen B, Karshafian R, Hynynen K (2012) Antitumor effects of combining docetaxel (taxotere) with the antivascular action of ultrasound stimulated microbubbles. PLoS One 7, e52307.
37. Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615–627.
38. Greco A, Di Benedetto A, Howard CM, Kelly S, Nande R, Dementieva Y, Miranda M, Brunetti A, Salvatore M, Claudio L, Sarkar D, Dent P, Curiel DT, Fisher PB, Claudio PP (2010) Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Mol Ther 18:295–306.
39. Grossman R, Tyler B, Hwang L, Zadnik P, Lal B, Javaherian K, Brem H (2011) Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin. J Neurosurg 115: 1139–1146.
40. Guarneri V, Dieci MV, Conte P (2012) Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer. Expert Opin Pharmacother 13:395–406.
41. Haag P, Frauscher F, Gradl J, Seitz A, Schafer G, Lindner JR, Klibanov AL, Bartsch G, Klocker H, Eder IE (2006) Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J Steroid Biochem Mol Biol 102:103–113.
42. Hauser J, Hauser M, Muhr G, Esenwein S (2009) Ultrasound-induced modifications of cytoskeletal components in osteoblast-like SAOS-2 cells. J Orthop Res 27:286–294.
43. Heath CH, Sorace A, Knowles J, Rosenthal E, Hoyt K (2012) Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in-vitro and in-vivo. Otolaryngol Head Neck Surg 146:938–945.
44. Helse Bergen H, Georg D (2010) Treatment of pancreatic adenocarcinoma by combining contrast agent and gemcitabine under sonication. Helse Bergen HF, Haukeland Unversity Hospital, Bergen
45. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95: 4607–4612.
46. Hoffmann A, Bredno J, Wendland M, Derugin N, Ohara P, Wintermark M (2011) High and low molecular weight fluorescein isothiocyanate (FITC)-dextrans to assess blood-brain barrier disruption: technical considerations. Transl Stroke Res 2:106–111.
47. Iwanaga K, Tominaga K, Yamamoto K, Habu M, Maeda H, Akifusa S, Tsujisawa T, Okinaga T, Fukuda J, Nishihara T (2007) Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 14:354–363.
48. Jain RK (1998) Delivery of molecular and cellular medicine to solid tumors. J Control Release 53:49–67.
49. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 6:69–90.
50. Juffermans LJ, Meijering BD, Henning RH, Deelman LE (2014) Ultrasound and microbubble-targeted delivery of small interfering RNA into primary endothelial cells is more effective than delivery of plasmid DNA. Ultrasound Med Biol 40:532–540.
51. Kaneko OF, Willmann JK (2012) Ultrasound for molecular imaging and therapy in cancer. Quant Imaging Med Surg 2:87–97.
52. Kiessling F, Fokong S, Koczera P, Lederle W, Lammers T (2012) Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med 53:345–348.
53. Kircher MF, Willmann JK (2012a) Molecular body imaging: MR imaging, CT, and US. Part I. Principles. Radiology 263:633–643.
54. Kircher MF, Willmann JK (2012b) Molecular body imaging: MR imaging, CT, and US. Part II. Applications. Radiology 264:349–368.
55. Kisker O, Becker CM, Prox D, Fannon M, D’Amato R, Flynn E, Fogler WE, Sim BK, Allred EN, Pirie- Shepherd SR, Folkman J (2001) Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 61:7669–7674.
56. Kohane DS, Tse JY, Yeo Y, Padera R, Shubina M, Langer R (2006) Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res A 77:351–361.
57. Kotopoulis S, Dimcevski G, Gilja OH, Hoem D, Postema M (2013) Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med Phys 40:072902.
58. Kotopoulis S, Delalande A, Popa M, Mamaeva V, Dimcevski G, Gilja OH, Postema M, Gjertsen BT, McCormack E (2014) Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft. Mol Imaging Biol 16:53–62.
59. Kun Y, Lin S (2014) Safety study of combining ultrasound microbubbles and chemotherapy to treat malignant neoplasms of liver metastases from gastrointestinal tumors and pancreatic carcinoma. Beijing Cancer Hospital, Beijing
60. Leslie TA, Kennedy JE (2006) High-intensity focused ultrasound principles, current uses, and potential for the future. Ultrasound Q 22:263–272.
61. Liao ZK, Tsai KC, Wang HT, Tseng SH, Deng WP, Chen WS, Hwang LH (2012) Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors. Cancer Gene Ther 19:171–180.
62. Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, Yang HW, Huang CY, Wang JJ, Yen TC, Wei KC (2010) Bloodbrain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255:415–425.
63. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O’Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128.
64. Lutz AM, Bachawal SV, Drescher CW, Pysz MA, Willmann JK, Gambhir SS (2014) Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model. Clin Cancer Res 5: 1313–1322.
65. Markman M, Rowinsky E, Hakes T, Reichman B, Jones W, Lewis JL Jr, Rubin S, Curtin J, Barakat R, Phillips M et al (1992) Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study. J Clin Oncol 10: 1485–1491.
66. Matsuo M, Yamaguchi K, Feril LB Jr, Endo H, Ogawa K, Tachibana K, Nakayama J (2011) Synergistic inhibition of malignant melanoma proliferation by melphalan combined with ultrasound and microbubbles. Ultrason Sonochem 18:1218–1224.
67. Meijering BD, Juffermans LJ, van Wamel A, Henning RH, Zuhorn IS, Emmer M, Versteilen AM, Paulus WJ, van Gilst WH, Kooiman K, de Jong N, Musters RJ, Deelman LE, Kamp O (2009) Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 104:679–687.
68. Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6:583–592.
69. Molema G, Meijer DK, de Leij LF (1998) Tumor vasculature targeted therapies: getting the players organized. Biochem Pharmacol 55:1939–1945.
70. Mow VC, Mak AF, Lai WM, Rosenberg LC, Tang LH (1984) Viscoelastic properties of proteoglycan subunits and aggregates in varying solution concentrations. J Biomech 17:325–338.
71. Newman CM, Bettinger T (2007) Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther 14:465–475.
72. Nie F, Xu HX, Lu MD, Wang Y, Tang Q (2008) Antiangiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: an in-vivo experimental study. J Drug Target 16:389–395.
73. O’Brien WD Jr (2007) Ultrasound-biophysics mechanisms. Prog Biophys Mol Biol 93:212–255.
74. Oda Y, Suzuki R, Otake S, Nishiie N, Hirata K, Koshima R, Nomura T, Utoguchi N, Kudo N, Tachibana K, Maruyama K (2012) Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis. J Control Release 160:362–366.
75. Panje CM, Wang DS, Pysz MA, Paulmurugan R, Ren Y, Tranquart F, Tian L, Willmann JK (2012) Ultrasoundmediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in-vivo transfection efficiency. Theranostics 2: 1078–1091.
76. Panje CM, Wang DS, Willmann JK (2013) Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives. Invest Radiol 48:755–769.
77. Paproski RJ, Yao SY, Favis N, Evans D, Young JD, Cass CE, Zemp RJ (2013) Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake. PLoS One 8, e56423.
78. Park J, Zhang Y, Vykhodtseva N, Akula JD, McDannold NJ (2012a) Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles. PLoS One 7, e42754.
79. Park EJ, Zhang YZ, Vykhodtseva N, McDannold N (2012b) Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 163:277–284.
80. Parvizi J, Parpura V, Greenleaf JF, Bolander ME (2002) Calcium signaling is required for ultrasoundstimulated aggrecan synthesis by rat chondrocytes. J Orthop Res 20:51–57.
81. Patil AV, Rychak JJ, Klibanov AL, Hossack JA (2011) Real-time technique for improving molecular imaging and guiding drug delivery in large blood vessels: in-vitro and ex vivo results. Mol Imaging 10:238–247.
82. Pu C, Chang S, Sun J, Zhu S, Liu H, Zhu Y, Wang Z, Xu RX (2014) Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts. Mol Pharm 11:49–58.
83. Pysz MA, Willmann JK (2011) Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging. Gastroenterology 140:785–790.
84. Qin S, Caskey CF, Ferrara KW (2009) Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol 54:R27–R57.
85. Rahman AM, Yusuf SW, Ewer MS (2007) Anthracyclineinduced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomed 2:567–583.
86. Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V, Prausnitz MR (2006) Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 32:915–924.
87. Schneider M (2008) Molecular imaging and ultrasound-assisted drug delivery. J Endourol 22:795–802.
88. Sever A, Jones S, Cox K, Weeks J, Mills P, Jones P (2009) Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer. Br J Surg 96:1295–1299.
89. Sheikov N, McDannold N, Sharma S, Hynynen K (2008) Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 34:1093–1104.
90. Shillitoe EJ (2009) Gene therapy: the end of the rainbow? Head Neck Oncol 1:7.
91. Sirsi SR, Borden MA (2014) State-of-the-art materials for ultrasound-triggered drug delivery. Adv Drug Deliv Rev 72:3–14.
92. Sonoda S, Tachibana K, Uchino E, Yamashita T, Sakoda K, Sonoda KH, Hisatomi T, Izumi Y, Sakamoto T (2007) Inhibition of melanoma by ultrasoundmicrobubble- aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 6:1276–1283.
93. Sorace AG, Warram JM, Umphrey H, Hoyt K (2012) Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. J Drug Target 20:43–54.
94. Sorace AG, Korb M, Warram JM, Umphrey H, Zinn KR, Rosenthal E, Hoyt K (2014) Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer. Ultrasound Med Biol 40:755–764.
95. Suzuki R, Namai E, Oda Y, Nishiie N, Otake S, Koshima R, Hirata K, Taira Y, Utoguchi N, Negishi Y, Nakagawa S, Maruyama K (2010) Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 142:245–250.
96. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234.
97. Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N, Aoki M, Ogihara T,Yasufumi K, Morishita R (2002) Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105:1233–1239.
98. Timmerman JM, Levy R (1999) Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med 50:507–529.
99. Ting CY, Fan CH, Liu HL, Huang CY, Hsieh HY, Yen TC, Wei KC, Yeh CK (2012) Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 33:704–712.
100. Todorova M, Agache V, Mortazavi O, Chen B, Karshafian R, Hynynen K, Man S, Kerbel RS, Goertz DE (2013) Antitumor effects of combining metronomic chemotherapy with the antivascular action of ultrasound stimulated microbubbles. Int J Cancer 132:2956–2966.
101. Tong AW, Jay CM, Senzer N, Maples PB, Nemunaitis J (2009) Systemic therapeutic gene delivery for cancer: crafting Paris’ arrow. Curr Gene Ther 9:45–60.
102. Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K (2012) Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 38:1716–1725.
103. Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL (2007) Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel. Pharm Res 24:1691–1701.
104. Tzu-Yin W, Wilson KE, Machtaler S, Willmann JK (2014) Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications. Curr Pharm Biotechnol 14:743–752
105. van Wamel A, Bouakaz A, Versluis M, de Jong N (2004) Micromanipulation of endothelial cells: ultrasoundmicrobubble- cell interaction. Ultrasound Med Biol 30:1255–1258
106. van Wamel A, Kooiman K, Emmer M, ten Cate FJ, Versluis M, de Jong N (2006) Ultrasound microbubble induced endothelial cell permeability. J Control Release 116:e100–e102.
107. Waite CL, Roth CM (2012) Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Crit Rev Biomed Eng 40:21–41.
108. Wang Y, Yuan F (2006) Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement. Ann Biomed Eng 34:114–127.
109. Wang DS, Panje C, Pysz MA, Paulmurugan R, Rosenberg J, Gambhir SS, Schneider M, Willmann JK (2012) Cationic versus neutral microbubbles for ultrasoundmediated gene delivery in cancer. Radiology 264:721–732.
110. Wang XL, Zhao XY, Li S, Jia CJ, Jiang L, Shi TM, Ren WD (2013a) A novel plasmid and SonoVue formulation plus ultrasound sonication for effective gene delivery in nude mice. Life Sci 93:536–542.
111. Wang Y, Bai WK, Shen E, Hu B (2013b) Sonoporation by low-frequency and low-power ultrasound enhances chemotherapeutic efficacy in prostate cancer cells. Oncol Lett 6:495–498.
112. Ward M, Wu J, Chiu JF (2000) Experimental study of the effects of optison concentration on sonoporation in- vitro. Ultrasound Med Biol 26:1169–1175.
113. Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7:591–607.
114. Wilson KE, Wang TY, Willmann JK (2013) Acoustic and photoacoustic molecular imaging of cancer. J Nucl Med 54:1851–1854.
115. Wood AK, Bunte RM, Price HE, Deitz MS, Tsai JH, Lee WM, Sehgal CM (2008) The disruption of murine tumor neovasculature by low-intensity ultrasound-comparison between 1- and 3-MHz sonication frequencies. Acad Radiol 15:1133–1141.
116. Xing W, Gang WZ, Yong Z, Yi ZY, Shan XC, Tao RH (2008) Treatment of xenografted ovarian carcinoma using paclitaxel-loaded ultrasound microbubbles. Acad Radiol 15:1574–1579.
117. Yamaguchi K, Feril LB Jr, Tachibana K, Takahashi A, Matsuo M, Endo H, Harada Y, Nakayama J (2011) Ultrasound-mediated interferon beta gene transfection inhibits growth of malignant melanoma. Biochem Biophys Res Commun 411:137–142.
118. Yan F, Li L, Deng Z, Jin Q, Chen J, Yang W, Yeh CK, Wu J, Shandas R, Liu X, Zheng H (2013) Paclitaxelliposome- microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J Control Release 166(3):246–255.
119. Yu BF, Wu J, Zhang Y, Sung HW, Xie J, Li RK (2013) Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma. Cancer Gene Ther 20:290–297.
120. Zhang JZ, Saggar JK, Zhou ZL, Hu B (2012) Different effects of sonoporation on cell morphology and viability. Bosn J Basic Med Sci 12:64–68.
121. Zhao YZ, Dai DD, Lu CT, Lv HF, Zhang Y, Li X, Li WF, Wu Y, Jiang L, Li XK, Huang PT, Chen LJ, Lin M (2012) Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in-vitro and in-vivo. Drug Dev Ind Pharm 38:1090–1098.
122. Zhou S, Li S, Liu Z, Tang Y, Wang Z, Gong J, Liu C (2010) Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice. J Exp Clin Cancer Res 29:170.
123. Zimm S, Cleary SM, Lucas WE, Weiss RJ, Markman M, Andrews PA, Schiefer MA, Kim S, Horton C, Howell SB (1987) Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide. Cancer Res 47:1712–1716.